According to DataM Intelligence, the Europe Sickle Cell Disease Treatment Market was valued at approximately USD 1.12 billion in 2024 and is projected to reach USD 1.87 billion by 2032, growing a...
According to recent insights by DataM Intelligence, the blood cancer drugs market is projected to reach USD 75.4 billion by 2032, up from an estimated USD 38.9 billion in 2024. This surge is fuel...